Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.

Journal of neurology - 1 Mar 2020

Schneider Susanne A, Alcalay Roy N

Abstract excerpt

In recent years, numerous clinical trials for disease modification in Parkinson's disease (PD) have failed, possibly because of a "one-size-fits all" approach. Alternatively, a precision medicine approach, which customises treatments based on patients' individual genotype, may help reach disease modification. Here, we review clinical trials that target genetic forms of PD, i.e., GBA-associated and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Genetic Predisposition to Disease
Share to Glucosylceramidase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Molecular Targeted Therapy

Share to Mutation

Share to Parkinson Disease

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 31974807
DOI: 10.1007/s00415-020-09705-7
PMCID: PMC7035220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.PMID 31974807Read ↗

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.Semantic proximity Read ↗

Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.Semantic proximity Read ↗

GBA1-and LRRK2-directed Treatments: The Way Forward.Semantic proximity Read ↗

New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin.Semantic proximity Read ↗

Precision medicine for disease modification in Parkinson diseaseSemantic proximity Read ↗

Disease‑Modifying Therapies for Parkinson’s Disease: Biological Mechanisms, Pharmacological Strategies, and Clinical PipelineSemantic proximity Read ↗

Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2Semantic proximity Read ↗

The genetic background of Parkinson's disease and novel therapeutic targets.Semantic proximity Read ↗

Precision medicine for Parkinson’s disease: The subtyping challengeSemantic proximity Read ↗

Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review.Semantic proximity Read ↗

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.Semantic proximity Read ↗

Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.